Fulgent Genetics Inc. (FLGT)
17.03
-0.02 (-0.12%)
At close: Mar 31, 2025, 10:33 AM
Fulgent Genetics Cash Flow Statement
| Year | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY01 |
| Net Income | -43.82M | -167.82M | 141.92M | 506.24M | 214.31M | -411K | -5.61M | -2.51M | -5.39M | -4.99M | -990K | 507.36M |
| Depreciation & Amortization | 22.23M | 26.14M | 32.66M | 11M | 2.96M | 2.11M | 2.16M | 1.73M | 1.17M | 575K | 196K | 11M |
| Stock-Based Compensation | 42.92M | 42.92M | 32.64M | 15.88M | 8.16M | 3.21M | 2.3M | 2.12M | 4.65M | 8.16M | n/a | 15.88M |
| Other Working Capital | n/a | 7.35M | -41.29M | -32.77M | 64.41M | 253K | 36.8M | 29.93M | 22.82M | 2.24M | 274K | n/a |
| Other Non-Cash Items | 4.88M | 115.31M | 43.46M | 15.97M | 8.05M | 1.55M | 1.67M | 1.04M | 5.58M | 362K | -3.28M | -534.25M |
| Deferred Income Tax | -5.15M | 7.61M | 831K | -7.84M | -1.4M | -21K | 36K | -336K | 246K | -3.33M | n/a | n/a |
| Change in Working Capital | n/a | 2.84M | 2M | -2.68M | -91.45M | -915K | -1.24M | -714K | -1.86M | -1.75M | -323K | n/a |
| Operating Cash Flow | 21.06M | 27M | 253.52M | 538.58M | 140.63M | 5.52M | -675K | 1.33M | 4.41M | -969K | -4.4M | 534.25M |
| Capital Expenditures | -40.31M | -22.21M | -18.77M | -23.84M | -36.51M | -1.32M | -2.83M | -5.36M | -3.79M | -2.1M | -731K | n/a |
| Acquisitions | -399K | -399K | -182.68M | -61.87M | -2.59M | 137K | 510K | 2.46M | 10K | 3.57M | n/a | n/a |
| Purchase of Investments | -491.91M | -491.91M | -432.98M | -730.49M | -324.36M | -52.08M | -24.19M | -11.66M | -39.02M | n/a | n/a | n/a |
| Sales Maturities Of Investments | 552.64M | 552.64M | 372.71M | 269.59M | 37.01M | 24.35M | 27.97M | 14.97M | n/a | n/a | n/a | n/a |
| Other Investing Acitivies | 775K | 775K | 412K | 63K | 8K | -137K | -510K | -2.46M | 10K | -105K | -49K | n/a |
| Investing Cash Flow | 38.9M | 38.9M | -261.31M | -546.55M | -326.44M | -29.05M | 950K | -2.05M | -42.8M | -2.21M | -780K | n/a |
| Debt Repayment | -1.77M | -5M | -1.07M | -11K | 15.02M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Common Stock Repurchased | -3.12M | -27.79M | -76.11M | -4.16M | -62K | -21K | n/a | n/a | n/a | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -4.59M | n/a | n/a | n/a |
| Other Financial Acitivies | -42.89M | -15M | 31K | 96K | 104K | 17K | 15K | -770K | 13.59M | 3.5M | 4M | n/a |
| Financial Cash Flow | -47.78M | -47.78M | -77.14M | 85.39M | 261.25M | 28.77M | 15K | -770K | 45.79M | 3.5M | 4M | n/a |
| Net Cash Flow | 17.97M | 17.97M | -85.39M | 77.47M | 75.46M | 5.23M | 246K | -1.41M | 7.4M | 326K | -1.18M | 534.25M |
| Free Cash Flow | -19.25M | 4.8M | 234.75M | 514.73M | 104.12M | 4.2M | -3.51M | -4.03M | 617K | -3.07M | -5.13M | 534.25M |